Cargando…

Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report

BACKGROUND: Epithelioid cell histiocytoma (ECH), which is also known as epithelioid benign fibrous histiocytoma, has been classified as a rare variant of fibrous histiocytoma (FH). However, the recent detection of ALK protein expression and/or ALK gene rearrangement in ECH suggests that it might be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakayama, Ryuko, Togashi, Yuki, Baba, Satoko, Kaku, Yo, Teramoto, Yuki, Sakurai, Takaki, Haga, Hironori, Takeuchi, Kengo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946425/ https://www.ncbi.nlm.nih.gov/pubmed/29747676 http://dx.doi.org/10.1186/s13000-018-0704-1

Ejemplares similares

Epithelioid Fibrous Histiocytoma with CARS-ALK Fusion: First Case Report
por: Secco, Léo-Paul, et al.
Publicado: (2023)

KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only
por: Togashi, Yuki, et al.
Publicado: (2012)

Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib
por: Sunga, Cass G. G., et al.
Publicado: (2023)

Dermoscopy of Solitary Epithelioid Histiocytoma of the Scalp: A Novel Feature
por: Rout, Aradhana, et al.
Publicado: (2021)

Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion
por: Li, XiaoQing, et al.
Publicado: (2023)

Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma
por: Jiang, Quan, et al.
Publicado: (2017)

ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report
por: Kai, Keita, et al.
Publicado: (2022)

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer
por: Sakashita, Takuya, et al.
Publicado: (2022)

Malignant Fibrous Histiocytoma with In-Transit Metastasis
por: Fujimura, Taku, et al.
Publicado: (2011)

Scapular Angiomatoid Fibrous Histiocytoma with EWSR1-CREB1 Fusion in an Adult Patient
por: Kobayashi, Hiroshi, et al.
Publicado: (2021)

TERT Promoter Mutation and Extent of Thyroidectomy in Patients with 1–4 cm Intrathyroidal Papillary Carcinoma
por: Ebina, Aya, et al.
Publicado: (2020)

IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions
por: Okabayshi, Misuzu, et al.
Publicado: (2020)

Mediastinal epithelioid hemangioendothelioma with abundant spindle cells and osteoclast-like giant cells mimicking malignant fibrous histiocytoma
por: Li, Xiao-Man, et al.
Publicado: (2013)

Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes
por: Ninomiya, Hironori, et al.
Publicado: (2013)

TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis
por: Dobashi, Akito, et al.
Publicado: (2018)

High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis
por: Kunieda, Junko, et al.
Publicado: (2022)

EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report
por: Zhang, Shuai, et al.
Publicado: (2022)

Atypical Cutaneous Fibrous Histiocytoma: An Unusual and Misleading Variant of Fibrous Histiocytoma
por: Ben Abdelkrim, Soumaya, et al.
Publicado: (2011)

Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
por: Li, Mengmeng, et al.
Publicado: (2023)

The Use of Crizotinib in Sclerosing Epithelioid Fibrosarcoma with ALK Mutation: A Case Report
por: Badran, Ahmed, et al.
Publicado: (2023)

Benign Fibrous Histiocytoma
por: Varma, Pushpa, et al.
Publicado: (2014)

Generalized eruptive histiocytoma
por: Aggarwal, Kamal, et al.
Publicado: (2010)

Deep fibrous histiocytoma of the index finger: a case report
por: Shibayama, Hiroki, et al.
Publicado: (2023)

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma
por: Fordham, Ashleigh M., et al.
Publicado: (2020)

Malignant fibrous histiocytoma originating from the mesorectum: a case report
por: Nakayama, Yoshifumi, et al.
Publicado: (2011)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

ALK Inhibitors-Induced M Phase Delay Contributes to the Suppression of Cell Proliferation
por: Munira, Sirajam, et al.
Publicado: (2020)

Malignant Fibrous Histiocytoma of The Pancreas
por: Garvey, J. F. W., et al.
Publicado: (1989)

Benign fibrous histiocytoma of the bladder
por: De Padua, Michelle, et al.
Publicado: (2007)

Benign Fibrous Histiocytoma of the Conjunctiva
por: Ryan, Geoffrey, et al.
Publicado: (2012)

Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis
por: Haga, Sanae, et al.
Publicado: (2017)

SQSTM1 Mutations and Glaucoma
por: Scheetz, Todd E., et al.
Publicado: (2016)

Malignant Fibrous Histiocytoma of Chest Wall
por: An, Jin-Kyung, et al.
Publicado: (2005)

Primary Malignant Fibrous Histiocytoma of the Pleura
por: Cho, Kyung-Hwa, et al.
Publicado: (2013)

Primary Pulmonary Malignant Fibrous Histiocytoma
por: Patel, Devin P., et al.
Publicado: (2015)

Benign fibrous histiocytoma of the lower lip
por: Anand, Nagaraja, et al.
Publicado: (2020)

Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
por: Takeyasu, Yuki, et al.
Publicado: (2021)

Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report
por: Wang, Zhan, et al.
Publicado: (2022)

Case report: ALK-rearranged spindle and epithelioid cell neoplasms with S100 and CD34 co-expression: Additional evidence of kinase fusion–positive soft tissue tumors
por: Sheng, Shao-Jie, et al.
Publicado: (2022)

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
por: Cha, Yoon Jin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3eca7ergsp7f1vldphasha0nbu